Markus Pfirrmann
Impact in
- Hematology top 0.5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 60
- Chronic Myeloid Leukemia Treatments 57
- Acute Myeloid Leukemia Research 8
- Genetics 53
- Chronic Lymphocytic Leukemia Research 42
- Myeloproliferative Neoplasms: Diagnosis and Treatment 10
- Diabetes and associated disorders 3
- Co-authors
- Joerg HasfordRüdiger HehlmannSusanne SaußeleHanneke C. Kluin‐NelemansJuan Luis SteegmannMichele BaccaraniN. C. AllanG. Alimena
- Journals
- Blood (21 papers)Leukemia (14 papers)Journal of Cancer Research and Clinical Oncology (3 papers)Seminars in Hematology (2 papers)Haematologica (2 papers)
- Partner nations
- GermanyNetherlandsSweden
In The Last Decade
Markus Pfirrmann
65 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Hematology 1.9k
- Genetics 1.7k
- Rheumatology 967
- Pathology and Forensic Medicine 264
- Critical Care and Intensive Care Medicine 56
Countries citing papers authored by Markus Pfirrmann
This map shows the geographic impact of Markus Pfirrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Pfirrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Pfirrmann more than expected).
Fields of papers citing papers by Markus Pfirrmann
This network shows the impact of papers produced by Markus Pfirrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Pfirrmann. The network helps show where Markus Pfirrmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Markus Pfirrmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 11 | |
| 4 | 2022 | 25 | |
| 5 | 2021 | 21 | |
| 6 | 2021 | 17 | |
| 7 | 2018 | 73 | |
| 8 | 2014 | 19 | |
| 9 | 2014 | 7 | |
| 10 | 2013 | 42 | |
| 11 | 2010 | 21 | |
| 12 | 2009 | 27 | |
| 13 | 2009 | 69 | |
| 14 | 2008 | 111 | |
| 15 | 2005 | 54 | |
| 16 | The impact of the combination of baseline risk group and cytogenetic response on the survival of patients with chronic myeloid leukemia treated with interferon alpha. | 2005 | 10 |
| 17 | 2004 | 6 | |
| 18 | 2003 | 35 | |
| 19 | A New Prognostic Score for Survival of Patients With Chronic Myeloid Leukemia Treated With Interferon Alfa Writing Committee for the Collaborative CML Prognostic Factors Project Group Hit paper breakdown → | 1998 | 518 |
| 20 | Analysis and validation of prognostic factors for CML | 1996 | 23 |
About Markus Pfirrmann
Markus Pfirrmann is a scholar working on Hematology, Genetics, Rheumatology, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health, having authored 71 papers that have together received 2.5k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (57 papers), Chronic Lymphocytic Leukemia Research (42 papers), Eosinophilic Disorders and Syndromes (25 papers), Lymphoma Diagnosis and Treatment (13 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers), Acute Myeloid Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (8 papers) and Diabetes and associated disorders (3 papers). The work is most often cited by research in Hematology (1.9k citations), Genetics (1.7k citations), Rheumatology (967 citations), Pathology and Forensic Medicine (264 citations) and Critical Care and Intensive Care Medicine (56 citations). Markus Pfirrmann has collaborated with scholars based in Germany, Netherlands and Sweden. Frequent co-authors include Joerg Hasford, Rüdiger Hehlmann, Susanne Saußele, Hanneke C. Kluin‐Nelemans, Juan Luis Steegmann, Michele Baccarani, N. C. Allan, G. Alimena, Michele Baccarani and Hassan Ansari. Their work appears in journals such as Blood, Leukemia, Journal of Cancer Research and Clinical Oncology, Seminars in Hematology and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.